Aya et al. show that the production of alternative BRAF mRNA isoforms (altBRAFs), associated with resistance to BRAF inhibitors in melanoma, is caused by genomic deletions rather than by alternative splicing, as previously thought. They also find that altBRAFs are present in treatment-naive, non-V600 BRAF-mutant and BRAF wild-type mutant tumors.
Related Posts
A fitness landscape instability governs the morphological diversity of tip-growing cells
Ohairwe et al. demonstrate that an intrinsic mechanical instability in the convergent mechanism of “inflationary” cell growth shared by diverse tip-growing cells leads to a bifurcation (branching) of their fitness landscape. This bifurcation strictly constrains natural tip-growing cell shapes.
Distributed X chromosome inactivation in brain circuitry is associated with X-linked disease penetrance of behavior
Szelenyi et al. demonstrate that adult brain XCI is systematically biased toward maternal X-active cells, which is sufficient for disease penetrance of the X-linked Fmr1-KO allele. Furthermore, local XCI mosaicism distinguishes phenotypic outcomes of individuals based on mutant X-active cells populating […]
Neospora caninum, a Protozoan Killing Dogs, “Might Be Key” to “Total Regression of Tumors”
Neosporosis, caused by the intracellular parasite Neospora caninum, presents a significant challenge in veterinary medicine, leading to serious and life-threatening neurological issues in dogs, and costing the industrial cattle industry billions each year. N. caninum does not infect humans, making […]